56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Filiou MD, Teplytska L, Nussbaumer M, Otte DM, Zimmer A, Turck CW. Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice. Journal of Personalized Medicine. 12. PMID 35207732 DOI: 10.3390/jpm12020244  0.307
2020 Martins-de-Souza D, Guest PC, Reis-de-Oliveira G, Schmitt A, Falkai P, Turck CW. An overview of the human brain myelin proteome and differences associated with schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-32. PMID 32602824 DOI: 10.1080/15622975.2020.1789217  0.62
2018 Park DI, Štambuk J, Razdorov G, Pučić-Baković M, Martins-de-Souza D, Lauc G, Turck CW. Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response. Scientific Reports. 8: 179. PMID 29317657 DOI: 10.1038/S41598-017-17500-0  0.496
2017 Turck CW, Guest PC, Maccarrone G, Ising M, Kloiber S, Lucae S, Holsboer F, Martins-de-Souza D. Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response. Frontiers in Molecular Neuroscience. 10: 272. PMID 28912679 DOI: 10.3389/Fnmol.2017.00272  0.544
2017 Maccarrone G, Bonfiglio JJ, Silberstein S, Turck CW, Martins-de-Souza D. Characterization of a Protein Interactome by Co-Immunoprecipitation and Shotgun Mass Spectrometry. Methods in Molecular Biology (Clifton, N.J.). 1546: 223-234. PMID 27896772 DOI: 10.1007/978-1-4939-6730-8_19  0.562
2016 Café-Mendes CC, Ferro ES, Torrão AS, Crunfli F, Rioli V, Schmitt A, Falkai P, Britto LR, Turck CW, Martins-de-Souza D. Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. Journal of Proteomics. PMID 27321914 DOI: 10.1016/J.Jprot.2016.05.025  0.627
2016 Cassoli JS, Iwata K, Steiner J, Guest PC, Turck CW, Nascimento JM, Martins-de-Souza D. Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes. Frontiers in Cellular Neuroscience. 10: 52. PMID 26973466 DOI: 10.3389/Fncel.2016.00052  0.633
2015 Guest PC, Iwata K, Kato TA, Steiner J, Schmitt A, Turck CW, Martins-de-Souza D. MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. Frontiers in Cellular Neuroscience. 9: 180. PMID 26029051 DOI: 10.3389/Fncel.2015.00180  0.597
2015 Martins-de-Souza D, Cassoli JS, Nascimento JM, Hensley K, Guest PC, Velasco AP, Turck CW. The protein interactome of collapsing response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. Proteomics. Clinical Applications. PMID 25921334 DOI: 10.1002/Prca.201500004  0.587
2015 Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, Möller HJ, Dean B. Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 25899066 DOI: 10.1093/Ijnp/Pyv042  0.493
2015 Filiou M, Wood P, Teplytska L, Otte D, Zimmer A, Turck C. Altered myelination in schizophrenia: Evidence from animal models and human cohorts Pharmacopsychiatry. 48. DOI: 10.1055/S-0035-1557955  0.316
2014 Steiner J, Martins-de-Souza D, Schiltz K, Sarnyai Z, Westphal S, Isermann B, Dobrowolny H, Turck CW, Bogerts B, Bernstein HG, Horvath TL, Schild L, Keilhoff G. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. Frontiers in Cellular Neuroscience. 8: 384. PMID 25477781 DOI: 10.3389/Fncel.2014.00384  0.546
2014 Wood PL, Filiou MD, Otte DM, Zimmer A, Turck CW. Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse. Schizophrenia Research. 159: 365-9. PMID 25263995 DOI: 10.1016/j.schres.2014.08.029  0.323
2014 Martins-de-Souza D, Maccarrone G, Ising M, Kloiber S, Lucae S, Holsboer F, Turck CW. Blood mononuclear cell proteome suggests integrin and Ras signaling as critical pathways for antidepressant treatment response. Biological Psychiatry. 76: e15-7. PMID 24607422 DOI: 10.1016/J.Biopsych.2014.01.022  0.461
2014 Steiner J, Schmitt A, Schroeter ML, Bogerts B, Falkai P, Turck CW, Martins-de-Souza D. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. European Archives of Psychiatry and Clinical Neuroscience. 264: 311-6. PMID 24504531 DOI: 10.1007/S00406-014-0490-Z  0.625
2014 Martins-de-Souza D, Maccarrone G, Ising M, Kloiber S, Lucae S, Holsboer F, Turck CW. Plasma fibrinogen: now also an antidepressant response marker? Translational Psychiatry. 4: e352. PMID 24473443 DOI: 10.1038/Tp.2013.129  0.49
2014 Martins-de-Souza D, Carvalho PC, Schmitt A, Junqueira M, Nogueira FC, Turck CW, Domont GB. Deciphering the human brain proteome: characterization of the anterior temporal lobe and corpus callosum as part of the Chromosome 15-centric Human Proteome Project. Journal of Proteome Research. 13: 147-57. PMID 24274931 DOI: 10.1021/Pr4009157  0.555
2013 Iwata K, Café-Mendes CC, Schmitt A, Steiner J, Manabe T, Matsuzaki H, Falkai P, Turck CW, Martins-de-Souza D. The human oligodendrocyte proteome. Proteomics. 13: 3548-53. PMID 24167090 DOI: 10.1002/Pmic.201300201  0.618
2013 Maccarrone G, Ditzen C, Yassouridis A, Rewerts C, Uhr M, Uhlen M, Holsboer F, Turck CW. Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters. Journal of Psychiatric Research. 47: 1572-80. PMID 23962679 DOI: 10.1016/J.Jpsychires.2013.07.021  0.366
2013 Schmitt A, Turck CW, Pilz PK, Malchow B, von Wilmsdorff M, Falkai P, Martins-de-Souza D. Proteomic similarities between heterozygous reeler mice and schizophrenia. Biological Psychiatry. 74: e5-e10. PMID 23684383 DOI: 10.1016/J.Biopsych.2013.03.023  0.58
2013 Guest PC, Martins-de-Souza D, Schwarz E, Rahmoune H, Alsaif M, Tomasik J, Turck CW, Bahn S. Proteomic profiling in schizophrenia: enabling stratification for more effective treatment. Genome Medicine. 5: 25. PMID 23531373 DOI: 10.1186/Gm429  0.7
2013 Maccarrone G, Rewerts C, Lebar M, Turck CW, Martins-de-Souza D. Proteome profiling of peripheral mononuclear cells from human blood. Proteomics. 13: 893-7. PMID 23281267 DOI: 10.1002/Pmic.201200377  0.544
2013 Filiou M, Teplytska L, Otte D, Zimmer A, Turck C. Unraveling the role of G72 in schizophrenia by quantitative proteomics Pharmacopsychiatry. 46. DOI: 10.1055/S-0033-1353263  0.349
2012 Filiou MD, Teplytska L, Otte DM, Zimmer A, Turck CW. Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. Journal of Psychiatric Research. 46: 1359-65. PMID 22884423 DOI: 10.1016/j.jpsychires.2012.07.004  0.378
2012 Martins-de-Souza D, Turck CW. Proteomic biomarkers for psychiatric disorders: a progress update. Biomarkers in Medicine. 6: 189-92. PMID 22448792 DOI: 10.2217/Bmm.12.6  0.518
2012 Knapman A, Kaltwasser SF, Martins-de-Souza D, Holsboer F, Landgraf R, Turck CW, Czisch M, Touma C. Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. The European Journal of Neuroscience. 35: 412-22. PMID 22288479 DOI: 10.1111/J.1460-9568.2011.07968.X  0.52
2012 Filiou MD, Martins-de-Souza D, Guest PC, Bahn S, Turck CW. To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics. 12: 736-47. PMID 22247077 DOI: 10.1002/Pmic.201100350  0.615
2012 Varadarajulu J, Schmitt A, Falkai P, Alsaif M, Turck CW, Martins-de-Souza D. Differential expression of HINT1 in schizophrenia brain tissue. European Archives of Psychiatry and Clinical Neuroscience. 262: 167-72. PMID 21553311 DOI: 10.1007/S00406-011-0216-4  0.65
2012 Martins-de-Souza D, Maccarrone G, Schmitt A, Falkai P, Dias-Neto E, Gattaz WF, Turck CW. PROTEOME ANALYSES OF POST-MORTEM BRAIN TISSUE FROM PATIENTS WITH SCHIZOPHRENIA SUGGEST DYSFUNCTION OF OLIGODENDROCYTES AND ASTROCYTES AND POTENTIAL BIOMARKER CANDIDATES? Schizophrenia Research. 136: S61. DOI: 10.1016/S0920-9964(12)70231-1  0.748
2011 Zhang Y, Reckow S, Webhofer C, Boehme M, Gormanns P, Egge-Jacobsen WM, Turck CW. Proteome scale turnover analysis in live animals using stable isotope metabolic labeling. Analytical Chemistry. 83: 1665-72. PMID 21314131 DOI: 10.1021/ac102755n  0.313
2011 Filiou MD, Turck CW, Martins-de-Souza D. Quantitative proteomics for investigating psychiatric disorders. Proteomics. Clinical Applications. 5: 38-49. PMID 21280236 DOI: 10.1002/Prca.201000060  0.569
2011 Martins-de-Souza D, Lebar M, Turck CW. Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 261: 217-28. PMID 21088845 DOI: 10.1007/S00406-010-0166-2  0.61
2011 Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN, Souza GH, Marangoni S, Novello JC, Turck CW, Dias-Neto E. Erratum to Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia [Journal of Psychiatric Research (2009); 43(11): 978–86] Journal of Psychiatric Research. 45: 283. DOI: 10.1016/J.Jpsychires.2010.06.003  0.728
2010 Martins-de-Souza D, Maccarrone G, Wobrock T, Zerr I, Gormanns P, Reckow S, Falkai P, Schmitt A, Turck CW. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. Journal of Psychiatric Research. 44: 1176-89. PMID 20471030 DOI: 10.1016/J.Jpsychires.2010.04.014  0.651
2010 Martins-De-Souza D, Wobrock T, Zerr I, Schmitt A, Gawinecka J, Schneider-Axmann T, Falkai P, Turck CW. Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 719-28. PMID 20446881 DOI: 10.3109/15622971003758748  0.631
2010 Martins-de-Souza D, Schmitt A, Röder R, Lebar M, Schneider-Axmann T, Falkai P, Turck CW. Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. Journal of Psychiatric Research. 44: 989-91. PMID 20381070 DOI: 10.1016/J.Jpsychires.2010.03.003  0.673
2010 Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, Holsboer F, Bullmore ET, Middleton L, Merlo-Pich E, Alexander RC, et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. Plos One. 5: e9166. PMID 20161799 DOI: 10.1371/Journal.Pone.0009166  0.379
2010 Martins-De-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G, Turck CW, Gattaz WF. Proteome analysis of schizophrenia brain tissue. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 110-20. PMID 20109112 DOI: 10.3109/15622970903490626  0.759
2010 Maccarrone G, Turck CW, Martins-de-Souza D. Shotgun mass spectrometry workflow combining IEF and LC-MALDI-TOF/TOF. The Protein Journal. 29: 99-102. PMID 20091422 DOI: 10.1007/S10930-009-9227-7  0.601
2010 Martins-de-Souza D, Harris LW, Guest PC, Turck CW, Bahn S. The role of proteomics in depression research. European Archives of Psychiatry and Clinical Neuroscience. 260: 499-506. PMID 19997739 DOI: 10.1007/S00406-009-0093-2  0.602
2009 Frank E, Kessler MS, Filiou MD, Zhang Y, Maccarrone G, Reckow S, Bunck M, Heumann H, Turck CW, Landgraf R, Hambsch B. Stable isotope metabolic labeling with a novel N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologies. Plos One. 4: e7821. PMID 19915716 DOI: 10.1371/journal.pone.0007821  0.308
2009 Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E. Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. Bmc Psychiatry. 9: 17. PMID 19405953 DOI: 10.1186/1471-244X-9-17  0.78
2009 Martins-de-Souza D, Maccarrone G, Reckow S, Falkai P, Schmitt A, Turck CW. Shotgun mass spectrometry analysis of the human thalamus proteome. Journal of Separation Science. 32: 1231-6. PMID 19301323 DOI: 10.1002/Jssc.200900008  0.618
2009 Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 259: 151-63. PMID 19165527 DOI: 10.1007/S00406-008-0847-2  0.764
2009 Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN, Souza GH, Marangoni S, Novello JC, Turck CW, Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research. 43: 978-86. PMID 19110265 DOI: 10.1016/J.Jpsychires.2008.11.006  0.785
2009 Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarrone G, Turck CW, Dias-Neto E. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 275-89. PMID 19034380 DOI: 10.1007/S00702-008-0156-Y  0.78
2008 Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW. Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. Journal of Separation Science. 31: 3122-6. PMID 18693323 DOI: 10.1002/Jssc.200800224  0.741
2004 Maccarrone G, Birg I, Malisch E, Rosenhagen MC, Ditzen C, Chakel JA, Mandel F, Reimann A, Doertbudak CC, Haegler K, Holsboer F, Turck CW. In-depth analysis of the human CSF proteome using protein prefractionation Clinical Proteomics. 1: 333-364. DOI: 10.1385/Cp:1:3-4:333  0.313
2002 Hou VC, Lersch R, Gee SL, Ponthier JL, Lo AJ, Wu M, Turck CW, Koury M, Krainer AR, Mayeda A, Conboy JG. Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. The Embo Journal. 21: 6195-204. PMID 12426391 DOI: 10.1093/Emboj/Cdf625  0.3
1995 Jackman JK, Motto DG, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA, Findell PR. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells Journal of Biological Chemistry. 270: 7029-7032. PMID 7706237 DOI: 10.1074/Jbc.270.13.7029  0.328
1995 Maeda T, Devens BH, Fukuse S, Turck C, Webb DR. Evidence for a calcium regulated, bidirectional intronic promoter in the murine TCR V alpha 1 gene. International Immunology. 7: 1339-51. PMID 7495741 DOI: 10.1093/Intimm/7.8.1339  0.363
1991 Shanafelt MC, Hindersson P, Soderberg C, Mensi N, Turck CW, Webb D, Yssel H, Peltz G. T cell and antibody reactivity with the Borrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis Journal of Immunology. 146: 3985-3992. PMID 1709664  0.418
1990 Mensi N, Webb DR, Turck CW, Peltz GA. Characterization of Borrelia burgdorferi proteins reactive with antibodies in synovial fluid of a patient with Lyme arthritis. Infection and Immunity. 58: 2404-7. PMID 2365463 DOI: 10.1128/Iai.58.7.2404-2407.1990  0.522
1986 Turck CW, Kapp JA, Webb DR. Structural analyses of a monoclonal heterodimeric suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10. Journal of Immunology (Baltimore, Md. : 1950). 137: 1904-9. PMID 3489044  0.402
1986 Krupen K, Turck C, Stein S, Kapp JA, Webb DR. GAT antigen-specific suppressor factors. Methods in Enzymology. 116: 325-40. PMID 2935706 DOI: 10.1016/S0076-6879(85)16026-X  0.364
1985 Turck CW, Kapp JA, Webb DR. Purification and partial characterization of a monoclonal "second order" suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10. Journal of Immunology (Baltimore, Md. : 1950). 135: 3232-7. PMID 2413116  0.393
Show low-probability matches.